| 000 | 01582 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512133044.0 | ||
| 264 | 0 | _c19700410 | |
| 008 | 197004s 0 0 eng d | ||
| 022 | _a0080-6730 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWäre, M | |
| 245 | 0 | 0 |
_aClinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin. _h[electronic resource] |
| 260 |
_bScandinavian journal of respiratory diseases. Supplementum _c1969 |
||
| 300 |
_a59-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Hypersensitivity |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEthambutol _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFinland |
| 650 | 0 | 4 |
_aHearing Disorders _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPneumothorax _xchemically induced |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aVision Disorders _xchemically induced |
| 700 | 1 | _aHeinivaara, O | |
| 700 | 1 | _aElo, R | |
| 700 | 1 | _aTala, E | |
| 773 | 0 |
_tScandinavian journal of respiratory diseases. Supplementum _gvol. 69 _gp. 59-63 |
|
| 999 |
_c4909241 _d4909241 |
||